Flavonoid derivatives as adenosine receptor antagonists: A comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model

Journal of Medicinal Chemistry

Volumn 41, Issue 1, 1998, Pages 46-52

  Moro, Stefano ^a   Van Michiel Rhee, A ^a   Sanders, Lawrence H ^a   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR ANTAGONIST; ALPHA NAPHTHOFLAVONE; APIGENIN; CIRSIMARITIN; FLAVONOID; GALANGIN; HISPIDULIN; PENTAMETHYLMORIN; QUERCETIN; RHAMNETIN; UNCLASSIFIED DRUG; VISNAGIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CORRELATION FUNCTION; DRUG RECEPTOR BINDING; ELECTRICITY; MOLECULAR MODEL; NONHUMAN; PREDICTION; PROTEIN INTERACTION; RAT; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION;

BINDING SITES; COMPUTER SIMULATION; ELECTROSTATICS; FLAVONOIDS; KINETICS; LEAST-SQUARES ANALYSIS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 15444338833     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970446z     Document Type: Article

References (34)

1. Jacobson, K. A.; Suzuki, F. Recent Developments in Selective Agonists and Antagonists Acting at Purine and Pyrimidine Receptors. Drug Dev. Res. 1997, 39, 289-300.
2. Müller, C. AI Adenosine Receptor Antagonists. Exp. Opin. Ther. Patents 1997, 7, 419-440.
3. von Lubitz, D. K. J. E.; Lin, R. C. S.; Popik, P.; Carter, M. F.; Jacobson, K. A. Adenosine Ay Receptor Stimulation and Cerebral Ischemia. Eur. J. Pharmacol. 1994, 263, 59-67.
4. Strickler, J.; Jacobson, K A.; Liang, B. T. Direct Preconditioning of Cultured Chick Ventricular Myocytes: Novel Functions of Cardiac Adenosine AZA and AS Receptors. J. Clin. Invest. 1996, 74, 1773-1779.
5. Sajjadi, F. G.; Takabayashi, K.; Foster, A. C.; Domingo, R. C.; Firestein, G. S. Inhibition of TNF-alpha Expression by Adenosine-Role of AS Adenosine Receptors. J. Immunol. 1996, 756, 3435-3442.
6. Ji, X.-d.; Melman, N.; Jacobson, K. A. Interactions of Flavonoids and Other Phytochemicals with Adenosine Receptors. J. Med. Chem. 1996, 39, 781-788.
7. Karton, Y.; Jiang, J. L.; Ji, X.-d.; Melman, N.; Olah, M. E.; Stiles, G. L.; Jacobson, K. A. Synthesis and Biological-Activities of Flavonoid Derivatives as as Adenosine Receptor Antagonists. J. Med. Chem. 1996, 39, 2293-2301.
8. van Rhee, A. M.; Jiang, J. L.; Melman, N.; Olah, M. E.; Stiles, G. L.; Jacobson, K. A. Interaction of 1, 4-Dihydropyridine and Pyridine Derivatives with Adenosine Receptors - Selectivity for As Receptors. J. Med. Chem. 1996, 39, 2980-2989.
9. Jiang, J.-l.; van Rhee, A. M.; Chang, L.; Patchornik, A.; Evans, P.; Melman, N.; Jacobson, K. A. Structure Activity Relationships of 4-Phenylethynyl-6-phenyl-l, 4-dihydropyridines as Highly Selective AS Adenosine Receptor Antagonists J. Med. Chem. 1997, 40, 2596-2608.
10. Kirn, Y.-C.; Ji, X.-d.; Jacobson, K. A. Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS15943) are Selective for the Human As Receptor Subtype. J. Med. Chem. 1996, 39, 4142-4148.
11. Jacobson, M. A.; Chakravarty, P. K.; Johnson, R. G.; Norton, R. Novel Selective Nonxanthine AS Adenosine Receptor Antagonists. Drug Dev. Res. 1996, 37, 131.
12. Beaven, M. A.; Ramkumar, V.; Ali, H. Adenosine AS Receptors in Mast Cells. Trends Pharmacol. Sci. 1994, 15, 13-14.
13. Jacobson, K. A.; Kim, H. O.; Siddiqi, S. M.; Olah, M. E.; Stiles, G.; von Lubitz, D. K. J. E. As Adenosine Receptors: Design of Selective Ligands and Therapeutic Prospects. Drugs Future 1995, 20, 689-699.
14. Jacobson, K. A.; Park, K S.; Jiang, J.-l.; Kirn, Y.-C.; Olah, M. E.; Stiles, G. L.; Ji, X.-d. Pharmacological Characterization of Novel AS Adenosine Receptor-Selective -Antagonists. Neuropharmacology 1997, 36, 1157-1165.
15. Shin, Y.; Daly, J. W.; Jacobson, K. A. Activation of Phosphoinositide Breakdown in a Rat RBL-2H3 Mast Cell Line by Adenosine Analogues: Lack of Correlation with Affinity for ASAdenosine Receptor. Drug Dev. Res. 1996, 39, 36-46.
16. Linden, J.; Taylor, H. E.; Robeva, A. S.; Tucker, A. L.; Stehle, J. H.; Rivkees, S. A.; Fink, J. S.; Reppert, S. M. Molecular Cloning and Functional Expression of a Sheep AS Adenosine Receptor with Widespread Tissue Distribution. Mol. Pharmacol. 1993, 44, 524-532.
17. Salvatore, C. A.; Jacobson, M. A.; Taylor, H. E.; Linden, J.; Johnson, R. G. Molecular Cloning and Characterization of the Human Ay Adenosine Receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369.
18. Middleton, E., Jr. Some Biological Properties of Plant Flavonoids. Ann. Allergy 1988, 61 53-57.
19. Limasset, B.; le Doucen, C.; Dore, J. C.; Ojasoo, T.; Dämon, M.; Crastes de Faulet, A. Effects of Flavonoids on the Release of Reactive Oxygen Species by Stimulated Human Nëutrophils. Multivariate Analysis of Structure-Activity Relationships (SAR). Biochem. Pharmacol. 1993 46: 1257-1271.
20. Raghavan, K.; Buolamwini, J. K.; Kohn, K. W.; Weinstein, J. N. Three-Dimensional Quantitative Structure-activity Relationship (QSAR) of HIV Integrase Inhibitors: A Comparative Molecular Field Analysis (CoMFA) Study. J. Med. Chem. 1995, 38, 890-897.
21. Dai, R.; Jacobson, K. A.; Robinson, R. C.; Friedman, F. K. Differential Effects of Flavonoids on Testosterone-Metabolizing Cytochrome P450s. Life Sci. Pharmacology Lett. 1997, 61, PL75PL80.
22. The program SYBYL 6.3 is available from TRIPOS Associates, St. Louis, MO, 1993.
23. MOPAC 6.0 available from Quantum Chemistry Program Excange.
24. Frisch, M. J.; Trucks, G. W.; Head-Gordon, M.; Gill, P. M. W.; Wong, M. W.; Foresman, J. B.; Johnson, B. G.; Schlegel, H. B.; Robb, M. A.; Replogle, E. S.; Gomperts, R.; Andres, J. L.; Raghavachari, K.; Binkley, J. S.; Gonzalez, C.; Martin, R. L.; Fox, D. J.; Defrees, D. J.; Baker, J.; Stewart, J. J. P.; Pople, J. A. Gaussian 92, Gaussian, Inc.: Pittsburgh, PA, 1992.
25. Schwabe, U.; Trost, T. Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine. NaunynSchmiedeberg's Arch. Pharmacol. 1980, 373, 179-187.
26. Jarvis, M. F.; Schutz, R.; Hutchison, A. J.; Do, E.; Sills, M. A.; Williams, M. [3H]CGS 21680, an A2 Selective Adenosine Receptor Agonist Directly Labels A2 Receptors in Rat Brain Tissue. J. Pharmacol. Exp. Ther. 1989, 251, 888-893.
27. Olah, M. E.; Gallo-Rodriguez, C.; Jacobson, K. A.; Stiles, G. L. [125I]AB-MECA, a High Affinity Radioligand for the Rat AI Adenosine Receptor. Mol. Pharmacol. 1994, 45, 978-982.
28. Stewart, J. J. P. Optimization of Paramiters for Semiempirical Methods I. Methods. J. Comput. Chem. 1989, 10, 209-217.
29. Dewar, M. J. S.; Thiel, W. Ground States of Molecules. 38. The MNDO method. Approximations and Parameters. J. Am. Chem. Soc. 1977, 09, 4899-4905.
30. Dewar, M. J. S. E.; Zoebisch, G.; Healy, E. F. AMI: A New General Purpose Quantum Mechanical Molecular Model. J. Am. Chem. Soc. 1985, 707, 3902-3909.
31. Chirlian, L. E.; Francl, M M. Atomic Charges Derived from Electrostatic Potentials: A Detailed Study. J. Comput. Chem. 1987, 8, 894-905.
32. Wold, S.; Ruhe, A.; Wold, H.; Dunn, W. J. The Covariance Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses. SIAM J. Sci. Stat. Comput. 1994, 5 (3), 735-743.
33. Cramer, R. D.; Bunce, J. D.; Patterson, D. E.; Frank, I. E. Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies. Quantum Struct.-Act. Eelat. 1988, 7, 18-25.
34. Waller, C. L.; Oprea, T. I.; Giolitti, A.; Marshall, G. R. ThreeDimensional QSAR of Human Immunodeficiency Virus (I) Protease Inhibitors. 1. A CoMFA Study Employing Experimentally-Determined Alignment Rules. J. Med. Chem. 1993, 36, 4152-4160.